History and current perspectives on the use of drug formulations to decrease the abuse of prescription drugs

被引:14
|
作者
Schuster, Charles R. [1 ]
机构
[1] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Subst Abuse Res Div, Detroit, MI 48207 USA
关键词
formulations; college on problems of drug dependence; abuse liability; exempt preparations; history; regulation; international drug treaties;
D O I
10.1016/j.drugalcdep.2006.01.006
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This article is part of a supplemental issue of the journal devoted entirely to papers on how abuse liability of medications is affected by their formulation for medical use. This article reviews the history of abuse and addiction to medications in the United States and the legislation designed to control these problems. The provisions in legislation related specifically to formulations of medications designed to decrease their abuse potential will be noted. In addition, the role of the College on Problems of Drug Dependence (CPDD) as an organization initially founded to develop analgesic medications with less abuse potential than morphine is briefly reviewed. Examples of current approaches to the development of formulations of medications to decrease their abuse potential discussed in detail in the articles to follow are outlined. Finally, the use of behavioral economic analyses to better delineate the relative abuse potential of new medication formulations is discussed. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S8 / S14
页数:7
相关论文
共 50 条
  • [31] Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health
    Ali, Mir M.
    Dowd, William N.
    Classen, Timothy
    Mutter, Ryan
    Novak, Scott P.
    ADDICTIVE BEHAVIORS, 2017, 69 : 65 - 77
  • [32] Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?
    Kaddis, Atheer A.
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (01): : 30 - 31
  • [33] Current approaches for the discovery of drugs that deter substance and drug abuse
    Yasgar, Adam
    Simeonov, Anton
    EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (11) : 1319 - 1331
  • [34] The impact of Medicare prescription drug coverage on the use of antidementia drugs
    Nicole R Fowler
    Yi-Fan Chen
    Christiana A Thurton
    Aiju Men
    Eric G Rodriguez
    Julie M Donohue
    BMC Geriatrics, 13
  • [35] Rational Drug Use and Equivalent Drugs Price Analysis in Prescription
    Bahce, Asli
    Utku, Semih
    Atay, Canan Eren
    2015 MEDICAL TECHNOLOGIES NATIONAL CONFERENCE (TIPTEKNO), 2015,
  • [36] The impact of Medicare prescription drug coverage on the use of antidementia drugs
    Fowler, Nicole R.
    Chen, Yi-Fan
    Thurton, Christiana A.
    Men, Aiju
    Rodriguez, Eric G.
    Donohue, Julie M.
    BMC GERIATRICS, 2013, 13
  • [37] Does Medical Cannabis Use Increase or Decrease the Use of Opioid Analgesics and Other Prescription Drugs?
    Bachhuber, Marcus A.
    Arnsten, Julia H.
    Cunningham, Chinazo O.
    Sohler, Nancy
    JOURNAL OF ADDICTION MEDICINE, 2018, 12 (04) : 259 - 261
  • [38] Nonmedical Use of Prescription ADHD Stimulants and Preexisting Patterns of Drug Abuse
    Sweeney, Christine T.
    Sembower, Mark A.
    Ertischek, Michelle D.
    Shiffman, Saul
    Schnoll, Sidney H.
    JOURNAL OF ADDICTIVE DISEASES, 2013, 32 (01) : 1 - 10
  • [39] Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study
    McCabe, Sean E.
    West, Brady T.
    Morales, Michele
    Cranford, James A.
    Boyd, Carol J.
    ADDICTION, 2007, 102 (12) : 1920 - 1930
  • [40] Prevalence of Use, Abuse and Dependence: Benzodiazepines, Z-drugs and Prescription Opioids
    Wolter, Dirk
    SUCHTTHERAPIE, 2020, 21 (02) : 66 - 75